| Eli Lilly And Company | 208K | US$239M | 7.7% |
| Danaher Corporation | 1.08M | US$211M | 6.8% |
| Thermo Fisher Scientific Inc | 343K | US$197M | 6.3% |
| Unitedhealth Group Incorporated | 314K | US$130M | 4.2% |
| Johnson & Johnson | 460K | US$118M | 3.8% |
| Abbvie Inc. | 450K | US$113M | 3.6% |
| Argenx Se | 76,500 | US$65.3M | 2.1% |
| Merck & Company, Inc. | 500K | US$65.1M | 2.1% |
| West Pharmaceutical Services, Inc. | 188K | US$64.2M | 2.1% |
| Ascendis Pharma A/s | 250K | US$61M | 2.0% |
| Alnylam Pharmaceuticals, Inc. | 270K | US$55.5M | 1.8% |
| Agilent Technologies, Inc. | 395K | US$54.7M | 1.8% |
| Viatris Inc. | 2.96M | US$52M | 1.7% |
| Natera, Inc. | 192K | US$51.5M | 1.7% |
| Guardant Health, Inc. | 285K | US$46.2M | 1.5% |
| 10x Genomics, Inc. | 955K | US$45.1M | 1.4% |
| Revolution Medicines, Inc. | 240K | US$45.1M | 1.4% |
| Waters Corporation | 118K | US$44.5M | 1.4% |
| Oruka Therapeutics, Inc. | 428K | US$41.3M | 1.3% |
| Ucb S.a. | 160K | US$41.1M | 1.3% |
| Cvs Health Corporation | 385K | US$40.2M | 1.3% |
| Gilead Sciences, Inc. | 300K | US$39.1M | 1.3% |
| Boston Scientific Corporation | 820K | US$38.3M | 1.2% |
| Repligen Corporation | 270K | US$38.1M | 1.2% |
| Enliven Therapeutics, Inc. | 670K | US$36.7M | 1.2% |
| Cogent Biosciences, Inc. | 920K | US$35.8M | 1.1% |
| Royalty Pharma Plc | 600K | US$35.1M | 1.1% |
| Kiniksa Pharmaceuticals International, Plc | 460K | US$34.2M | 1.1% |
| Vaxcyte, Inc. | 630K | US$34.1M | 1.1% |
| Spyre Therapeutics, Inc. | 340K | US$33.4M | 1.1% |
| Jazz Pharmaceuticals Plc | 128K | US$32.4M | 1.0% |
| Moderna, Inc. | 585K | US$32.1M | 1.0% |
| Xenon Pharmaceuticals Inc. | 468K | US$29.3M | 0.94% |
| Bruker Corporation | 457K | US$28.7M | 0.92% |
| Illumina, Inc. | 138K | US$28.3M | 0.91% |
| Veracyte, Inc. | 600K | US$27.8M | 0.89% |
| Lifestance Health Group, Inc. | 2.5M | US$26.2M | 0.84% |
| Praxis Precision Medicines, Inc. | 82,800 | US$25.5M | 0.82% |
| Sartorius Stedim Biotech Sa | 125K | US$24M | 0.77% |
| Kymera Therapeutics, Inc. | 228K | US$23.6M | 0.76% |
| Roivant Sciences Ltd. | 640K | US$21.7M | 0.70% |
| Mbx Biosciences, Inc. | 328K | US$21.6M | 0.69% |
| Privia Health Group, Inc. | 897K | US$21.2M | 0.68% |
| Insmed Incorporated | 208K | US$20.5M | 0.66% |
| Biogen Inc. | 100K | US$20.3M | 0.65% |
| Relay Therapeutics, Inc. | 1.04M | US$19.6M | 0.63% |
| Cencora, Inc. | 60,000 | US$18.7M | 0.60% |
| Dianthus Therapeutics, Inc. | 163K | US$17.5M | 0.56% |
| Axsome Therapeutics, Inc. | 80,000 | US$17.4M | 0.56% |
| Cg Oncology, Inc. | 228K | US$16.2M | 0.52% |
| Zenas Biopharma, Inc. | 500K | US$15.7M | 0.50% |
| Disc Medicine, Inc. | 200K | US$15.4M | 0.49% |
| Mineralys Therapeutics, Inc. | 600K | US$15.3M | 0.49% |
| Brightspring Health Services, Inc. | 250K | US$14.9M | 0.48% |
| Caris Life Sciences, Inc. | 934K | US$14.6M | 0.47% |
| Beone Medicines Ltd. Class A | 46,000 | US$14.5M | 0.47% |
| Amylyx Pharmaceuticals, Inc. | 715K | US$14.5M | 0.47% |
| Viridian Therapeutics, Inc. | 760K | US$14.4M | 0.46% |
| Mirum Pharmaceuticals, Inc. | 128K | US$13.6M | 0.43% |
| Heartflow, Inc. | 520K | US$13.1M | 0.42% |
| Pharvaris N.v. | 400K | US$13M | 0.42% |
| Alumis Inc. | 460K | US$13M | 0.42% |
| Edwards Lifesciences Corporation | 150K | US$12.9M | 0.41% |
| Twist Bioscience Corporation | 135K | US$12.4M | 0.40% |
| Newamsterdam Pharma Company N.v. | 420K | US$11.7M | 0.37% |
| Travere Therapeutics, Inc. | 208K | US$11.6M | 0.37% |
| Kestra Medical Technologies, Ltd. | 471K | US$10.8M | 0.34% |
| Alignment Healthcare, Inc. | 708K | US$10.5M | 0.34% |
| Scholar Rock Holding Corporation | 218K | US$10.3M | 0.33% |
| Stoke Therapeutics, Inc. | 330K | US$9.52M | 0.31% |
| Olema Pharmaceuticals, Inc. | 820K | US$9.39M | 0.30% |
| Irhythm Holdings, Inc. | 80,000 | US$9.37M | 0.30% |
| Viking Therapeutics, Inc. | 280K | US$8.89M | 0.28% |
| First Tracks Biotherapeutics, Inc. | 200K | US$8.81M | 0.28% |
| Trevi Therapeutics, Inc. | 480K | US$8.76M | 0.28% |
| Cytomx Therapeutics, Inc. | 2.5M | US$7.75M | 0.25% |
| Jade Biosciences, Inc. | 371K | US$7.32M | 0.23% |
| Shoulder Innovations, Inc. | 311K | US$7.07M | 0.23% |
| Veradermics, Incorporated | 60,000 | US$6.3M | 0.20% |
| Edgewise Therapeutics, Inc. | 143K | US$5.5M | 0.18% |
| Summit Therapeutics Inc. | 400K | US$5.21M | 0.17% |
| Intuitive Surgical, Inc. | 14,000 | US$4.95M | 0.16% |
| Tyra Biosciences, Inc. | 140K | US$4.46M | 0.14% |
| Contineum Therapeutics, Inc. | 280K | US$4.34M | 0.14% |
| Alamar Biosciences, Inc. | 160K | US$4.06M | 0.13% |
| Annexon, Inc. | 750K | US$3.82M | 0.12% |
| Outset Medical, Inc. | 800K | US$3.66M | 0.12% |
| Gmr Solutions Inc. | 282K | US$3.64M | 0.12% |
| Climb Bio, Inc. | 214K | US$2.55M | 0.08% |
| Upstream Bio, Inc. | 400K | US$2.52M | 0.08% |
| Ocular Therapeutix, Inc. | 277K | US$2.27M | 0.07% |
| Crescent Biopharma, Inc. | 149K | US$2.16M | 0.07% |
| Hemab Therapeutics Holdings, Inc. | 33,000 | US$1.57M | 0.05% |
| Immunome, Inc. | 38,378 | US$873K | 0.03% |
| Cyclerion Therapeutics, Inc. | 1,500 | US$5,160 | <0.01% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Veeva Systems Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Acumen Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Tenet Healthcare Corporation | 0 | US$0 | 0.00% |